Author information:
(1)From Mount Vernon Cancer Centre, Northwood (P.N.), the Clatterbridge Cancer 
Centre NHS Foundation Trust, Wirral (J.J.S.), the University of Liverpool, 
Liverpool (J.J.S.), and Immunocore, Abingdon (S.E.A., C.H., H.G.) - all in the 
United Kingdom; the Department of Dermatology and the National Center for Tumor 
Diseases, University Hospital Heidelberg, Heidelberg (J.C.H.), the Department of 
Dermatology and Allergy, University Hospital, Ludwig Maximilian University of 
Munich, Munich (M.S.), the Department of Hematology and Oncology, 
Charité-Comprehensive Cancer Center (S.O.), Berlin, and the Department of 
Dermatology and the Center for Integrated Oncology, University Hospital Cologne, 
Cologne (C.M.) - all in Germany; Maria Sklodowska-Curie National Research 
Institute of Oncology, Warsaw, Poland (P.R.); Institut Roi Albert II des 
Cliniques Universitaires Saint-Luc and Université Catholique de Louvain, 
Brussels (J.-F.B.); Princess Margaret Cancer Centre, Toronto (M.O.B.); 
Massachusetts General Hospital Cancer Center, Boston (R.J.S.); the Department of 
Dermatology, University Hospital of Zurich, Zurich, Switzerland (R.D.); Hillman 
Cancer Center, University of Pittsburgh Medical Center, Pittsburgh (J.M.K.); 
Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia 
(M.O.); Kinghorn Cancer Centre, Saint Vincent's Hospital, Darlinghurst, NSW, 
Australia (A.M.J.); Memorial Sloan Kettering Cancer Center (A.N.S.) and Irving 
Medical Center, Columbia University (R.D.C.) - both in New York; Institut 
d'Investigació Biomèdica de Bellvitge-Centro de Investigación Biomédica en Red 
de Oncología, Institut Català d'Oncologia, Barcelona (J.M.P.); University of 
Iowa Hospitals and Clinics, Iowa City (M.M.); Duke University, Durham, NC 
(A.K.S.S.); Earle A. Chiles Research Institute, Providence Cancer Institute, 
Portland, OR (B.C.); N.N. Blokhin Cancer Research Center, Moscow (L.D.); Centre 
Antoine Lacassagne, Nice (L.G.) and Institut Curie, Paris Sciences and Letters 
Research University, Paris (S.P.-N.) - both in France; Winship Cancer Institute, 
Emory University, Atlanta (M.Y.); and the Angeles Clinic and Research Institute, 
a Cedars-Sinai Affiliate, Los Angeles (O.H.).